Panelists discuss how managing bronchiectasis exacerbations involves targeted antibiotics based on sputum cultures, augmenting mucus clearance with devices, and considering surgical intervention when medical management fails.
Clinical Brief: Approaches to Bronchiectasis Management Beyond Bronchodilators
Main Discussion Topics
Key Points for Physicians
Notable Insights
Patients may be unable to tolerate long-term antibiotics for conditions like MAI complex, making surgery an important consideration in treatment algorithms.
Clinical Significance
A comprehensive approach to bronchiectasis management should prioritize infection control and enhance mucus clearance, with bronchodilators playing a supporting rather than central role.
In R/R Marginal Zone Lymphoma, 90% Alive at 2 Years After Liso-Cel
June 24th 2025In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in challenging cases.
Read More